LON:AVO

Advanced Oncotherapy (AVO) Share Price, News & Analysis

Advanced Oncotherapy logo

About Advanced Oncotherapy Stock (LON:AVO)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
200,000 shs
Average Volume
1.27 million shs
Market Capitalization
£9.50 million
P/E Ratio
N/A
Dividend Yield
5.49%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AVO Stock News Headlines

AVO.L Regulatory News
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel
Advanced Oncotherapy Share Chat
Advanced Oncotherapy PLC AVO
See More Headlines

AVO Stock Analysis - Frequently Asked Questions

Advanced Oncotherapy plc (LON:AVO) released its quarterly earnings data on Monday, June, 29th. The company reported GBX (9.83) EPS for the quarter, missing analysts' consensus estimates of GBX (8.90) by GBX 0.93.

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Oncotherapy investors own include Oxford Biomedica (OXB), Motif Bio (MTFB), Applied Graphene Materials (AGM), BP (BP), Bahamas Petroleum (BPC), Glencore (GLEN) and Haydale Graphene Industries (HAYD).

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
LON:AVO
CIK
N/A
Fax
N/A
Employees
3,900
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£32.60 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-67.34%
Return on Assets
-11.73%

Debt

Debt-to-Equity Ratio
98.71
Current Ratio
1.26
Quick Ratio
0.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
33.50
Book Value
GBX 14 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
542,570,000
Free Float
N/A
Market Cap
£9.50 million
Optionable
Not Optionable
Beta
0.06
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (LON:AVO) was last updated on 8/30/2023 by MarketBeat.com Staff.
From Our Partners